Oppenheimer L; Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007;29:261-266.
1. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010;203:430-439.
2. Cunningham G, Leveno KJ, Bloom S, et al, eds. Williams obstetrics. 23rd ed. New York, NY: McGraw-Hill Professional; 2009.
3. Clark SL. Placenta previa and abruptio placentae. In: Creasy RK, Resnick R, Iams J, eds. Maternal-fetal medicine. 5th ed. Philadelphia, PA: WB Saunders; 2004:715.
4. National Patient Safety Agency (UK). Placenta praevia after caesarean section care bundle. February 2010. http://www.nrls.npsa.nhs.uk/ (last accessed 31 July 2017).
5. American College of Radiology. ACR appropriateness criteria: second and third trimester bleeding. 2013. http://www.acr.org/ (last accessed 31 July 2017).
6. Getahun D, Oyelese Y, Salihu HM, et al. Previous cesarean delivery and risks of placenta previa and placental abruption. Obstet Gynecol. 2006;107:771-778.
7. Loto O, Onile TG. Placenta praevia at the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife. A ten year analysis. Niger J Clin Pract. 2008;11:130-133.
8. Yang Q, Wu Wen S, Caughey S, et al. Placenta previa: its relationship with race and the country of origin among Asian women. Acta Obstet Gynecol Scand. 2008;87:612-616.
9. Odibo AO, Cahill AG, Stamilio DM, et al. Predicting placental abruption and previa in women with a previous cesarean delivery. Am J Perinatol. 2007;24:299-306.
10. Qublan HS, Tahat Y. Multiple cesarean section. The impact on maternal and fetal outcome. Saudi Med J. 2006;27:210-214.
11. Lynch CM, Kearney R, Turner MJ. Maternal morbidity after elective repeat cesarean section after two or more previous procedures. Eur J Obstet Gynecol Reprod Biol. 2003;106:10-13.
12. Cleary-Goldman J, Malone FD, Vidaver J, et al; FASTER Consortium. Impact of maternal age on obstetric outcome. Obstet Gynecol. 2005;105:983-990.
13. Ananth CV, Demissie K, Smulian JC, et al. Placenta previa in singleton and twin births in the United States, 1989 through 1998: a comparison of risk factor profiles and associated conditions. Am J Obstet Gynecol. 2003;188:275-281.
14. Mortensen JT, Thulstrup AM, Larsen H, et al. Smoking, sex of the offspring, and risk of placental abruption, placenta previa, and preeclampsia: a population-based cohort study. Acta Obstet Gynecol Scand. 2001;80:894-898.
15. Oppenheimer L; Society of Obstetricians and Gynaecologists of Canada. Diagnosis and management of placenta previa. J Obstet Gynaecol Can. 2007;29:261-266.
16. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006;107:927-941.
17. Montan S. Increased risk in the elderly parturient. Curr Opin Obstet Gynecol. 2007;19:110-112.
18. Joseph KS, Allen AC, Dodds L, et al. The perinatal effects of delayed childbearing. Obstet Gynecol. 2005;105:1410-1418.
19. Ziadeh S, Yahaya A. Pregnancy outcome at age 40 and older. Arch Gynecol Obstet. 2001;265:30-33.
20. Jolly M, Sebire N, Harris J, et al. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod. 2000;15:2433-2437.
21. Francois K, Johnson JM, Harris C. Is placenta previa more common in multiple gestations? Am J Obstet Gynecol. 2003;188:1226-1227.
22. Castles A, Adams EK, Melvin CL, et al. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med. 1999;16:208-215.
23. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005;192:1458-1461.
24. Thomson F, Shanbhag S, Templeton A, et al. Obstetric outcome in women with subfertility. BJOG. 2005;112:632-637.
25. Kallen B, Finnstrom O, Nygren KG, et al. In vitro fertilisation in Sweden: obstetric characteristics, maternal morbidity and mortality. BJOG. 2005;112:1529-1535.
26. Shevell T, Malone FD, Vidaver J, et al. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol. 2005;106:1039-1045.
27. Reddy UM, Wapner RJ, Rebar RW, et al. Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol. 2007;109:967-977.
28. Mukhopadhaya N, Arulkumaran S. Reproductive outcomes after in-vitro fertilization. Curr Opin Obstet Gynecol. 2007;19:113-119.
29. Romundstad LB, Romundstad PR, Sunde A, et al. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod. 2006;21:2353-2358.
30. Kashanian M, Akbarian AR, Baradaran H, et al. Pregnancy outcome following a previous spontaneous abortion (miscarriage). Gynecol Obstet Invest. 2006;61:167-170.
31. Sheiner E, Levy A, Katz M, et al. Pregnancy outcome following recurrent spontaneous abortions. Eur J Obstet Gynecol Reprod Biol. 2005;118:61-65.
32. Zhou W, Nielsen GL, Larsen H, et al. Induced abortion and placenta complications in the subsequent pregnancy. Acta Obstet Gynecol Scand. 2001;80:1115-1120.
33. Papinniemi M, Keski-Nisula L, Heinonen S. Placental ratio and risk of velamentous umbilical cord insertion are increased in women with placenta previa. Am J Perinatol. 2007;24:353-357.
34. Shukunami K, Tsunezawa W, Hosokawa K, et al. Placenta previa of a succenturiate lobe: a report of two cases. Eur J Obstet Gynecol Reprod Biol. 2001;99:276-277.
35. Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol. 2007;196:297-308.
36. Kistin N, Handler A, Davis F, et al. Cocaine and cigarettes: a comparison of risks. Paediatr Perinat Epidemiol. 1996;10:269-278.
37. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 101: ultrasonography in pregnancy. Obstet Gynecol. 2009;113:451-461.
38. Dashe JS, McIntire DD, Ramus RM, et al. Persistence of placenta previa according to gestational age at ultrasound detection. Obstet Gynecol. 2002;99:692-697.
39. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. Green-top guideline no. 27. January 2011. http://www.rcog.org.uk/ (last accessed 31 July 2017).
40. Vladareanu R, Onofriescu M, Mihailescu D, et al. Magnetic resonance imaging in obstetrics. Rev Med Chir Soc Med Nat Iasi. 2006;110:567-574.
41. Abramowicz JS, Sheiner E. In utero imaging of the placenta: importance for diseases of pregnancy. Placenta. 2007;28(suppl A):S14-S22.
42. Neilson JP. Interventions for suspected placenta praevia. Cochrane Database Syst Rev. 2003;(2):CD001998.
43. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand. 2005;84:716-724.
44. Chilaka VN, Konje JC, Clarke S, et al. Practice observed: is speculum examination on admission a necessary procedure in the management of all cases of antepartum haemorrhage? J Obstet Gynaecol. 2000;20:396-398.
45. Sakornbut E, Leeman L, Fontaine P. Late pregnancy bleeding. Am Fam Physician. 2007;75:1199-1206.
46. Magann EF, Cummings JE, Niederhauser A, et al. Antepartum bleeding of unknown origin in the second half of pregnancy: a review. Obstet Gynecol Surv. 2005;60:741-745.
47. Gagnon A, Wilson RD, Audibert F, et al; Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30:918-949.
48. Bhide A, Prefumo F, Moore J, et al. Placental edge to internal os distance in the late third trimester and mode of delivery in placenta praevia. BJOG. 2003;110:860-864.
49. Oppenheimer L, Holmes P, Simpson N, et al. Diagnosis of low-lying placenta: can migration in the third trimester predict outcome? Ultrasound Obstet Gynecol. 2001;18:100-102.
50. Predanic M, Perni SC, Baergen RN, et al. A sonographic assessment of different patterns of placenta previa "migration" in the third trimester of pregnancy. J Ultrasound Med. 2005;24:773-780.
51. Olive EC, Roberts CL, Nassar N, et al. Test characteristics of placental location screening by transabdominal ultrasound at 18-20 weeks. Ultrasound Obstet Gynecol. 2006;28:944-949.
52. Comstock CH, Love JJ, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol. 2004;190:1135-1140.
53. Adeyomoye AA, Ola ER, Arogundade RA, et al. Comparison of the accuracy of trans-abdominal sonography (TAS) and transperineal sonography (TPS) in the diagnosis of placenta praevia. Niger Postgrad Med J. 2006;13:21-25.
54. Garcia-Bournissen F, Shrim A, Koren G. Safety of gadolinium during pregnancy. Can Fam Physician. 2006;52:309-310.
55. American College of Obstetricians and Gynecologists. Management of alloimmunization during pregnancy: ACOG practice bulletin, No. 75. Obstet Gynecol. 2006;108:457-464.
56. Fan D, Wu S, Liu L, et al. Prevalence of antepartum hemorrhage in women with placenta previa: a systematic review and meta-analysis. Sci Rep. 2017;7:40320.
57. Bhide A, Thilaganathan B. Recent advances in the management of placenta previa. Curr Opin Obstet Gynecol. 2004;16:447-451.
58. Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2017 Nov 7. pii: S0140-6736(17)32455-8.
59. Love CD, Fernando KJ, Sargent L, et al. Major placenta praevia should not preclude out-patient management. Eur J Obstet Gynecol Reprod Biol. 2004;117:24-29.
60. Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;(3):CD004454.
61. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee opinion No. 475: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2011;117:422-424.
62. Crowther CA, McKinlay CJ, Middleton P, et al. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2015;(7):CD003935.
63. Bose DA, Assel BG, Hill JB, et al. Maintenance tocolytics for preterm symptomatic placenta previa: a review. Am J Perinatol. 2011;28:45-50.
64. American Congress of Obstetricians and Gynecologists. Management of preterm labor: ACOG practice bulletin No. 43. Int J Gynaecol Obstet. 2003;82:127-135.
65. Neilson JP, West HM, Dowswell T. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev. 2014;(2):CD004352.
66. European Medicines Agency. Restrictions on use of short-acting beta-agonists in obstetric indications - CMDh endorses PRAC recommendations. October 2013. http://www.ema.europa.eu/ema/ (last accessed 31 July 2017).
67. Flenady V, Wojcieszek AM, Papatsonis DN, et al. Calcium channel blockers for inhibiting preterm labour and birth. Cochrane Database Syst Rev. 2014;(6):CD002255.
68. Doyle LW, Crowther CA, Middleton P, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2009;(1):CD004661.
69. US Food and Drug Administration. Drug safety communication - FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. May 2013. http://www.fda.gov/ (last accessed 31 July 2017).
70. Becker RH, Vonk R, Mende BC, et al. The relevance of placental location at 20-23 gestational weeks for prediction of placenta previa at delivery: evaluation of 8650 cases. Ultrasound Obstet Gynecol. 2001;17:496-501.
71. Bergholt T, Stenderup JK, Vedsted-Jakobsen A, et al. Intraoperative surgical complication during cesarean section: an observational study of the incidence and risk factors. Acta Obstet Gynecol Scand. 2003;82:251-256.
72. Magan EF, Evans S, Hutchinson M, et al. Postpartum hemorrhage after cesarean delivery: an analysis of risk factors. South Med J. 2005;98:681-685.
73. Watanasomsiri N, Rungruxsrivorn T, Chaithongwongwatthana S. Risk factors for cesarean hysterectomy in cesarean delivery. J Med Assoc Thai. 2006;89(suppl 4):S100-S104.
74. Daskalakis G, Anastasakis E, Papantoniou, et al. Emergency obstetric hysterectomy. Acta Obstet Gynecol Scand. 2007;86:223-227.
75. Yang Q, Wen SW, Oppenheimer L, et al. Association of caesarean delivery for first birth with placenta praevia and placental abruption in second pregnancy. BJOG. 2007;114:609-613.
76. Kennare, R, Tucker G, Heard A, et al. Risks of adverse outcomes in the next birth after a first cesarean delivery. Obstet Gynecol. 2007;109:270-276.
77. American College of Obstetricians and Gynecologists. Vaginal birth after previous cesarean delivery: ACOG Practice Bulletin, No. 54. Obstet Gynecol. 2004;104:203-212.
78. Tuzovic L. Complete versus incomplete placenta previa and obstetric outcome. Int J Gynaecol Obstet. 2006;93:110-117.
79. Koifman A, Levy A, Zaulan Y, et al. The clinical significance of bleeding during the second trimester of pregnancy. Arch Gynecol Obstet. 2008;278:47-51.
80. Ananth CV, Demissie K, Smulian JC, et al. Relationship among placenta previa, fetal growth restriction, and preterm delivery: a population-based study. Obstet Gynecol. 2001;98:299-306.
81. Ananth CV, Smulian JC, Vintzileos AM. The effect of placenta previa on neonatal mortality: a population-based study in the United States, 1989 through 1997. Am J Obstet Gynecol. 2003;188:1299-1304.
82. Salihu HM, Li QL, Rouse DJ, et al. Placenta previa: neonatal death after live births in the United States. Am J Obstet Gynecol. 2003;188:1305-1309.
83. Lal AK, Hibbard JU. Placenta previa: an outcome-based cohort study in a contemporary obstetric population. Arch Gynecol Obstet. 2015;292:299-305.
84. Li DK, Wi S. Maternal placental abnormality and the risk of sudden infant death syndrome. Am J Epidemiol. 1999;149:608-611.
85. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol. 2010;115:637-644.
86. Machado LS. Emergency peripartum hysterectomy: Incidence, indications, risk factors and outcome. N Am J Med Sci. 2011;3:358-361.
87. Tanimura K, Yamasaki Y, Ebina Y, et al. Prediction of adherent placenta in pregnancy with placenta previa using ultrasonography and magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol. 2015;187C:41-44.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台